trial · primary record
Dexamethasone
Multiple Myeloma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2029-03-31 |
| Primary endpoint | Avoided or reduced systemic anticancer therapy (SACT) modifications per cycle |
| Registry ID | NCT07341867 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:30.937Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07341867
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Dexamethasone · approval
- Dexamethasone · compound